Mounjaro Dosing Schedule: Step-by-Step
Starting a new injection can feel daunting, but a clear, steady plan makes it much easier. The Mounjaro (tirzepatide) schedule is designed to be simple, predictable, and gentle on your system so you can build up gradually and give your body time to adjust. Whether you’re just beginning or moving up a dose, this guide walks you through each step with confidence and care.
Mounjaro, known generically as tirzepatide, is a once-weekly injection used for blood sugar control and weight management, with a structured “titration” plan that increases the dose slowly over time. This steady build helps improve results while reducing tummy-related side effects for most people. Think of it as a paced journey: start low, go slow, and find the dose that suits you best.
How the Dosing Ladder Works
Mounjaro starts at a low dose and steps up in small increments, typically every 4 weeks, until you reach a dose that you can tolerate and that supports your goals. The dosing ladder looks like this:
- Start: 2.5 mg once weekly for 4 weeks.
- Step up: Increase by 2.5 mg after at least 4 weeks on your current dose (for example, to 5 mg, then 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg if needed).
- Usual maintenance doses: 5 mg, 10 mg, or 15 mg once weekly, selected based on your response and how you feel.
- Maximum weekly dose: 15 mg.
Many UK guides present the same stepwise plan: begin at 2.5 mg weekly for the first month, then consider 5 mg, and continue in 2.5 mg steps at 4-week intervals if needed. Not everyone needs the highest dose; some people do well at 5 mg or 10 mg and can stay there longer if they prefer or if that’s what they tolerate best.
Your First 12 Weeks: A Simple Timeline
Weeks 1–4: 2.5 mg once weekly. This is the “get-started” dose, helping your body adjust; it isn’t meant to deliver full effect by itself.
Weeks 5–8: 5 mg once weekly (if well tolerated).
Weeks 9–12: 7.5 mg once weekly (if needed and tolerated).
From here, dose increases can continue in 2.5 mg steps after at least 4 weeks on the current dose (10 mg → 12.5 mg → 15 mg), depending on progress and tolerability, with 5 mg, 10 mg, or 15 mg as common long-term doses. UK materials mirror this rhythm and emphasise 4 weeks between changes.
Weekly Routine and Practical Tips
Keeping to the same day each week makes life easier and helps steady the medicine’s levels. You can take Mounjaro on any day, any time, with or without food, in the abdomen, thigh, or upper arm (rotate sites each week to reduce irritation). If plans change, you may switch your “Mounjaro day” as long as there are at least 3 days between doses.
Short checklist:
- Pick a consistent day and time each week.
- Rotate injection sites: tummy, thigh, or upper arm.
- Keep a simple calendar reminder for dose changes every 4 weeks, if planned.
If You Miss a Dose or Need to Change Your Day
Life happens. If you miss a dose, take it as soon as possible within 4 days (96 hours); if more than 4 days have passed, skip the missed dose and take the next one on your usual day. If you need to change your weekly dosing day, ensure there are at least 3 days between two injections.
Finding Your Maintenance Dose
The “right” dose is personal. Many people aim for the highest dose they can comfortably tolerate, but it’s perfectly acceptable to remain at a lower dose if it’s working for you and feels manageable. UK guidance also acknowledges that while many can titrate up, the best dose is the one that balances benefits with comfort.
Signs you might stay at a given dose longer:
- You’re feeling queasy or uncomfortable at the new level.
- You’re satisfied with your progress at 5 mg or 10 mg.
In either case, staying put for extra weeks (or indefinitely) is common and sensible.
What Clinical Trials and Guidance Suggest
Large trials used a gradual 2.5 mg step-up every 4 weeks from a 2.5 mg start, with many participants reaching higher maintenance doses by about 20 weeks when tolerated. UK prescribing references align closely with this schedule and cap the maximum at 15 mg weekly. Real-world practice often targets the highest tolerated dose, but tolerability and personal goals guide the final choice.
Expert Insights
“As with similar weekly injections, starting low and rising slowly helps people stick with treatment by easing stomach side effects,” says a typical UK primary care perspective, reflected in NICE’s appraisal discussion that stresses stepwise titration and using the highest tolerated dose when appropriate.
User Experiences
Many users describe appetite changes within the first few weeks. One UK account reported noticing a calmer appetite by week two and stepping up to 5 mg after the first month without issues, then taking longer before the next increase to keep queasiness at bay—an approach consistent with the 4-week interval and the option to pause at a comfortable dose.
Risks and Considerations
The main reason for slow titration is to reduce gastrointestinal effects like nausea or bloating, which are usually mild to moderate and tend to settle with time.
If side effects feel too strong, consider staying on the current dose for longer or stepping back down in discussion with your prescriber.
Key Takeaways
- Start at 2.5 mg weekly for 4 weeks, then increase by 2.5 mg no sooner than every 4 weeks if needed.
- Common maintenance doses are 5 mg, 10 mg, or 15 mg, with 15 mg as the maximum weekly dose.
- Missed a dose? Take it within 4 days, or skip and return to your usual day; keep at least 3 days between doses when changing your day.
- Staying longer at a lower dose is fine if it suits your goals and comfort.
- Keep injections once weekly, same day and time, rotating sites for comfort.
A steady, step-by-step plan makes Mounjaro dosing manageable—take it week by week, listen to your body, and adjust thoughtfully with your prescriber’s guidance.
For pricing and availability, check our price comparison tool.
Sources
- Summary of Product Characteristics: Mounjaro solution for injection — electronic Medicines Compendium (emc)
- Mounjaro: EPAR Product Information — European Medicines Agency
- Tirzepatide for managing overweight and obesity (TA924) — NICE
- Four-dose Mounjaro KwikPen approved — MHRA (GOV.UK)
- How to Use Mounjaro — Eli Lilly
- Tirzepatide Prescribing Support Information — BLMK ICB (NHS)
- Tirzepatide (Mounjaro) Initiation Guide — BOB ICB (NHS)
- Mounjaro (tirzepatide) US Prescribing Information (2022) — U.S. FDA
- Zepbound (tirzepatide) US Prescribing Information — Eli Lilly
- Tirzepatide — NCBI Bookshelf